Cargando…

High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia

BACKGROUND & AIMS: Glycogen storage disease type Ia (GSDIa) is an inborn error of carbohydrate metabolism caused by pathogenic variants in the glucose-6-phosphatase catalytic subunit 1 (G6PC1) gene and is associated with hepatocellular adenoma (HCA) formation. Data on risk factors for HCA occurr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haring, Martijn P.D., Peeks, Fabian, Oosterveer, Maaike H., Brouwers, Martijn C.G.J., Hollak, Carla E.M., Janssen, Mirian C.H., Langendonk, Janneke G., Rennings, Alexander J.M., Wagenmakers, Margreet A.E.M., Verkade, Henkjan J., Derks, Terry G.J., de Meijer, Vincent E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263528/ https://www.ncbi.nlm.nih.gov/pubmed/35811762 http://dx.doi.org/10.1016/j.jhepr.2022.100512

Ejemplares similares

Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control
por: Peeks, Fabian, et al.
Publicado: (2017)

Letter to the editor: Diagnosis of erythropoietic protoporphyria with severe liver injury - a case report
por: Wensink, Debby, et al.
Publicado: (2019)

A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets
por: Rossi, Alessandro, et al.
Publicado: (2022)

Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas
por: Moest, Wouter, et al.
Publicado: (2018)

Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
por: Hoogerland, Joanne A., et al.
Publicado: (2021)

Next-generation glycogen storage diseases
por: Derks, Terry G. J., et al.
Publicado: (2018)

A retrospective in‐depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management
por: Peeks, Fabian, et al.
Publicado: (2021)

Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions
por: Derks, Terry G. J., et al.
Publicado: (2015)

Towards values‐based healthcare for inherited metabolic disorders: An overview of current practices for persons with liver glycogen storage disease and fatty acid oxidation disorders
por: Venema, Annieke, et al.
Publicado: (2022)

Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
por: Rutten, Martijn G. S., et al.
Publicado: (2023)

Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
por: Derks, Terry G. J., et al.
Publicado: (2021)

Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR/CRISPR‐associated protein 9–Mediated Gene Editing
por: Rutten, Martijn G.S., et al.
Publicado: (2021)

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia
por: den Hollander, N. C., et al.
Publicado: (2007)

The potential of dietary treatment in patients with glycogen storage disease type IV
por: Derks, Terry G. J., et al.
Publicado: (2020)

Relevant patient characteristics for guiding tailored integrated diabetes primary care: a systematic review
por: Hertroijs, Dorijn F.L., et al.
Publicado: (2018)

Effects of fructose added to an oral glucose tolerance test on plasma glucose excursions in healthy adults
por: Buziau, Amée M., et al.
Publicado: (2023)

A triple-blinded crossover study to evaluate the short-term safety of sweet manioc starch for the treatment of glycogen storage disease type Ia
por: Monteiro, Vaneisse C. L., et al.
Publicado: (2021)

A preliminary study of telemedicine for patients with hepatic glycogen storage disease and their healthcare providers: from bedside to home site monitoring
por: Hoogeveen, Irene J., et al.
Publicado: (2018)

Kidney and vascular function in adult patients with hereditary fructose intolerance
por: Simons, Nynke, et al.
Publicado: (2020)

Relationship Between Nonalcoholic Fatty Liver Disease Susceptibility Genes and Coronary Artery Disease
por: Brouwers, Martijn C.G.J., et al.
Publicado: (2019)

Geneotype and phenotype in 20 patients with glycogen storage disease type Ia
por: Liang, Cuili, et al.
Publicado: (2013)

Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia
por: Kruger, Eliza, et al.
Publicado: (2023)

Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels
por: Saeed, Ali, et al.
Publicado: (2020)

Increased atherosclerosis in a mouse model of glycogen storage disease type 1a
por: La Rose, Anouk M., et al.
Publicado: (2022)

Glycogen Storage Disease Type Ia in Canines: A Model for Human Metabolic and Genetic Liver Disease
por: Specht, Andrew, et al.
Publicado: (2011)

Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)
por: Farah, Benjamin L., et al.
Publicado: (2017)

Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia
por: Kang, Hye-Ri, et al.
Publicado: (2019)

Development of hepatocellular adenomas in a patient with glycogen storage disease Ia treated with growth hormone therapy
por: Jackson, David G., et al.
Publicado: (2023)

Retrospective evaluation of the Dutch pre‐newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia: What to aim, expect, and evaluate from newborn screening?
por: Haijes, Hanneke A., et al.
Publicado: (2019)

Mortality in Pedigrees with Acute Intermittent Porphyria
por: Neeleman, Rochus, et al.
Publicado: (2022)

A retrospective study of eating and psychosocial problems in patients with hepatic glycogen storage diseases and idiopathic ketotic hypoglycemia: Towards a standard set of patient‐reported outcome measures
por: Venema, Annieke, et al.
Publicado: (2021)

Medical and financial burden of acute intermittent porphyria
por: Neeleman, Rochus A., et al.
Publicado: (2018)

Dynamic Methods for Childhood Hypoglycemia Phenotyping: A Narrative Review
por: Rossi, Alessandro, et al.
Publicado: (2022)

Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study
por: Jahja, Rianne, et al.
Publicado: (2016)

Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study
por: Jahja, Rianne, et al.
Publicado: (2017)

From Puppies to adults: In vivo editing of hepatocytes in a canine model of glycogen storage disease type Ia
por: Chandler, Randy J.
Publicado: (2023)

Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia
por: Korljan Jelaska, Betty, et al.
Publicado: (2013)

Identification of the fructose transporter GLUT5 (SLC2A5) as a novel target of nuclear receptor LXR
por: Zwarts, Irene, et al.
Publicado: (2019)

Research priorities for liver glycogen storage disease: An international priority setting partnership with the James Lind Alliance
por: Peeks, Fabian, et al.
Publicado: (2019)

Exploiting epigenetics for the treatment of inborn errors of metabolism
por: Rutten, Martijn G. S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n6s0qgaogi53fsjrbg42s9db85